Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 5:41 pm Purchase | 2025-06-30 | 13G | Avadel Pharmaceuticals plc AVDL | Two Seas Capital LP | 6,155,074 6.400% | 1,208,625 (+24.43%) | Filing History |
| 2025-08-13 5:40 pm Purchase | 2025-06-30 | 13G | Arbutus Biopharma Corporation ABUS | Two Seas Capital LP | 10,443,317 5.400% | 2,055,929 (+24.51%) | Filing History |
| 2025-08-13 5:38 pm Purchase | 2025-06-30 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 3,154,808 9.500% | 201,118 (+6.81%) | Filing History |
| 2025-08-08 09:40 am Purchase | 2025-08-07 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 19,122,842 6.300% | 19,122,842 (New Position) | Filing History |
| 2025-08-08 08:53 am Purchase | 2025-08-07 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 19,122,842 6.300% | 19,122,842 (New Position) | Filing History |
| 2025-07-29 3:17 pm Sale | 2025-07-25 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 11,662,308 9.300% | -422,369 (-3.50%) | Filing History |
| 2025-07-14 2:27 pm Purchase | 2025-07-10 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 12,084,677 9.700% | 12,279 (+0.10%) | Filing History |
| 2025-06-18 3:59 pm Purchase | 2025-06-17 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 12,072,398 9.700% | 191,472 (+1.61%) | Filing History |
| 2025-05-22 4:45 pm Purchase | 2025-05-20 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 11,880,926 9.500% | 301,107 (+2.60%) | Filing History |
| 2025-05-15 09:01 am Purchase | 2025-03-31 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 2,953,690 9.990% | 5,943 (+0.20%) | Filing History |
| 2025-05-15 09:00 am Purchase | 2025-03-31 | 13G | Adaptimmune Therapeutics plc ADAPY | Two Seas Capital LP | 123,178,110 8.000% | 34,167,234 (+38.39%) | Filing History |
| 2025-05-15 09:00 am Purchase | 2025-03-31 | 13G | Avadel Pharmaceuticals plc AVDL | Two Seas Capital LP | 4,946,449 5.100% | 4,946,449 (New Position) | Filing History |
| 2025-03-04 5:22 pm Sale | 2025-03-03 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 11,579,819 9.300% | -427,695 (-3.56%) | Filing History |
| 2025-02-14 09:32 am Purchase | 2024-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 2,947,747 9.990% | 1,131,363 (+62.29%) | Filing History |
| 2025-02-14 09:31 am Purchase | 2024-12-31 | 13G | Adaptimmune Therapeutics plc ADAPY | Two Seas Capital LP | 89,010,876 5.800% | 89,010,876 (New Position) | Filing History |
| 2025-01-17 4:20 pm Sale | 2025-01-15 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 12,007,514 9.600% | -1,022,513 (-7.85%) | Filing History |
| 2024-11-14 08:43 am Sale | 2024-09-30 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 1,816,384 8.100% | -266,254 (-12.78%) | Filing History |
| 2024-11-14 08:42 am Sale | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 6,584,278 3.300% | -1,101,842 (-14.34%) | Filing History |
| 2024-11-14 08:41 am Sale | 2024-09-30 | 13G | Arbutus Biopharma Corporation ABUS | Two Seas Capital LP | 8,387,388 4.400% | -654,539 (-7.24%) | Filing History |
| 2024-10-17 2:53 pm Sale | 2024-10-15 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 13,030,027 10.100% | -229,998 (-1.73%) | Filing History |